VAVeronica Allen

Veronica Allen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Veronica Allen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Mark Patrick Nicol

    Marshall Centre, Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia

    3 shared publications
  • Faye Black

    Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

    2 shared publications
  • Heather Jessica Zar

    Department of Pediatrics and Child Health, Red Cross War Memorial Children’s Hospital, University of Cape Town, Cape Town, South Africa

    2 shared publications
  • Jacinta Munro

    Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

    2 shared publications
  • Lesley Workman

    Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa

    2 shared publications
  • Washiefa Isaacs

    Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

    2 shared publications

Latest Publications

  • Open Access

    Investigating the population structure of Moraxella catarrhalis using a cgMLST scheme and LIN code system

    by Iman Yassine, Keith A. Jolley, James E. Bray, Melissa J. Jansen van Rensburg, Fadheela Patel, Anna E. Sheppard, Heather J. Zar, Veronica Allen, Lemese Ah Tow, Martin C. J. Maiden, et al.

    Moraxella catarrhalis is an important cause of infectious exacerbations of chronic obstructive pulmonary disease and otitis media. To investigate the population structure of M. catarrhalis, we developed a core-genome multilocus sequence typing (cgMLST) scheme using 1319 core genes, and a life identification number (LIN) barcode classification system. Whole-genome analyses of nearly 2000 genomes confirmed divergent seroresistant (SR) and serosensitive (SS) M. catarrhalis lineages with distinct evolutionary trajectories. SR genomes are more conserved, while SS genomes exhibited greater genetic variability. Virulence gene analyses revealed lineage-specific variations in ubiquitous surface proteins (UspA1 and UspA2) and lipooligosaccharide (LOS) types. The bro β-lactamase, and mcb bacteriocin cluster, are more common in SR lineages, which suggested different selective pressures and adaptation. Here, we show that this cgMLST scheme and LIN code system provide a robust method for characterising M. catarrhalis, distinguish between SR and SS lineages, and offer a unified framework for population structure analyses.


  • Open Access

    Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study

    by Mark P Nicol, Veronica Allen, Lesley Workman, Washiefa Isaacs, Jacinta Munro, Sandra Pienaar, Faye Black, Layla Adonis, Widaad Zemanay, Yonas Ghebrekristos, et al.


  • Open Access

    Rapid Molecular Diagnosis of Pulmonary Tuberculosis in Children Using Nasopharyngeal Specimens

    by Heather J. Zar, Lesley Workman, Washiefa Isaacs, Jacinta Munro, Faye Black, Brian Eley, Veronica Allen, Catharina C. Boehme, Widaad Zemanay, Mark P. Nicol

    Background. A rapid diagnosis of pediatric pulmonary tuberculosis (PTB) using Xpert MTB/RIF (Mycobacterium tuberculosis/rifampicin) automated testing on induced sputum (IS) is possible, but the capacity for performing IS is limited. The diagnosis using a nasopharyngeal aspirate (NPA), which can be non-invasively obtained, is desirable. Methods. Paired specimens (NPA and IS) were tested using smear, liquid culture and Xpert. The diagnostic accuracy of Xpert and smear was compared with culture for different specimens in children with suspected PTB. Results. There were 535 children [median age 19 months, 117 (21·9%) HIV-infected] who had one IS and one NPA specimen; 396 had two paired specimens. A positive smear, Xpert test or culture occurred in 30 (5.6%), 81 (15.1%) and 87 children (16.3%), respectively. The culture yield was higher from IS (84/87, 96.6%) vs NPA (61/87, 70.1%, P < .001). Amongst children with two paired specimens, 63 culture-confirmed cases occurred [60 (95.2%) IS vs 48 (76.2%) NPA, P = .002]. The sensitivity of two Xpert tests was similar for IS and NPAs [(45/63) 71% vs (41/63) 65%, P = .444)]; the sensitivity of smear was lower for IS (21/63, 33%) and NPA (16/63, 25%). The incremental yield from a second IS was 9 cases (17.6%) by culture and 9 (25%) by Xpert testing; a second NPA increased the culture yield by 10 (26.3%) and Xpert by 11 (36.7%). Xpert specificity was 99.1% (98.1–100) for IS and 98.2% (96.8–99.6) for NPAs. Xpert testing provided faster results than culture (median 0 vs 15 days, P < .001). Conclusions. Xpert testing on 2 NPAs is useful in children with suspected PTB, particularly in settings where IS and culture are not feasible.